SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IN_GOD_I_TRUST who wrote (445)8/21/1997 1:19:00 AM
From: DIVYA DUTTA   of 998
 
To All,

When is decision expected on european approval for Myotrophin?

If Myotrophin is approved in Europe before Nov 11, that would put a lot of pressure on FDA, to at least conditionally approve it for marketing in U.S.

Has Cephalon done / submitted any study based on the ALS patients in U.S., who are currently receiving Myotrophin?

What other drugs are in Cephalon's pipeline?

If Myotrophin is approved in U.S., where is the stock expected to trade?

Any thoughts would be appreciated.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News